About MVision AI
MVision AI develops automatic segmentation and contouring software. The software integrates with hospital systems to provide contours of various critical structures. The company was founded in 2017 and is based in Helsinki, Finland.
Expert Collections containing MVision AI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MVision AI is included in 2 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest MVision AI News
Nov 2, 2023
Finnish satellite imagery startup Kuva Space has netted €16.6 million in Series A funding. The round was led by existing investors Voima Ventures known for investing in MVision AI and eniferBio and Nordic Foodtech VC, with Singapore-based Earth VC also participating. The round also includes Finnish private investors through a growth funding initiative with Springvest and non-equity funding from Business Finland. With this round, the total funding raised by the company accounts for €22.5 million. Kuva Space will use the capital to accelerate the development of its patented hyperspectral camera and space technology, double its team size, and launch its AI analytics platform. The company also plans to expand its presence in key markets, starting with the United States. The Finnish startup is also set to establish a business development organisation in the United States, allowing them to better understand customer requirements and timelines. This move will not only enable them to collaborate more flexibly with existing US capabilities but also create new funding opportunities. Ambitious launch plans The company plans to launch two commercial hyperspectral microsatellites in 2024, with the long-term goal of deploying up to 100 satellites by 2030. This extensive satellite network will offer customers unprecedented spatial resolution of better than 10 metres per pixel. In addition, subscription plans will provide daily hyperspectral monitoring starting in 2026 and increase to three daily views by 2030. The funding comes close on the heels of the company being announced the NATO Arctic Challenge Innovation winner. Also, it received a €5 million commercial contract from the European Commission to be the sole provider of hyperspectral data services for the Copernicus program. World’s first microsatellite constellation Founded by Janne Kuhno and Tuomas Tikka in 2016, Kuva Space is building the world’s first extensive microsatellite constellation with patented hyperspectral camera technology. It collects gapless data aimed at solving the world’s most pressing issues, such as climate change, food security and safety. Combined with its AI-driven analytics platform, Kuva Space delivers reliable, timely, global insights and foresights that transform rich spaceborne data into actionable insights users can use for efficient resource management, optimised operations, and improved profitability sustainably. “Our growth funding campaign was oversubscribed in less than three days. We are extremely excited that our investors share our mission to improve life on Earth. We firmly believe that quality and timely spaceborne insights will empower communities to make informed decisions and create a sustainable future,” noted Jarkko Antila, CEO of Kuva Space. “With this funding round, we are well-equipped to accelerate our satellite launches, enhance our AI analytics platform with proprietary data, and further our market expansion, particularly in the United States.” “As an early investor, we have been big believers of Kuva Space’s pioneering work both in defense applications, as well as improving upon how we track and measure society’s environmental impact,” affirmed Inka Mero, chairwoman of Kuva Space board, founder and CEO of Voima Ventures, known for its strategic investments in groundbreaking Nordic deep tech companies. ”With Finland’s emergence as a European leader in space technology, we’re extremely excited about what the future holds for Kuva Space.” Nordic Foodtech VC, a forward-looking investor focused on shaping the future of food technology, echoes this sentiment. “The exceptional technology of Kuva Space enables a step change in resource-efficient farming and monitoring and mitigating the environmental impacts of global food production,” said Jari Tuovinen, partner at Nordic Foodtech VC.
MVision AI Frequently Asked Questions (FAQ)
When was MVision AI founded?
MVision AI was founded in 2017.
Where is MVision AI's headquarters?
MVision AI's headquarters is located at c/o Terkko Health Hub Haartmaninkatu 4, Helsinki.
What is MVision AI's latest funding round?
MVision AI's latest funding round is Series A.
How much did MVision AI raise?
MVision AI raised a total of $8.26M.
Who are the investors of MVision AI?
Investors of MVision AI include Voima Ventures, J12 Ventures, Icebreaker, Nuard Ventures, Asko Schrey and 3 more.
Who are MVision AI's competitors?
Competitors of MVision AI include Synaptiq and 2 more.
Compare MVision AI to Competitors
Elekta (STO: EKTA-B) operates as a human-care company focusing on clinical solutions for treating cancer and brain disorders. The company develops tools and treatment-planning systems for radiation therapy and radiosurgery, as well as workflow-enhancing software systems across the spectrum of cancer care. Its line of products includes radiation therapy, stereotactic radiosurgery, oncology software, brachytherapy, neurosurgery, veterinary radiation therapy, and life sciences. The company was founded in 1972 and is based in Stockholm, Sweden.
Manteia is a company that focuses on adaptive radiotherapy treatment, operating within the healthcare and technology sectors. The company offers intelligent medical image processing solutions for radiation therapy, adaptive radiotherapy treatment planning systems, a radiotherapy AI model training platform, and an online adaptive plan QA system. These services primarily cater to the healthcare industry, specifically cancer centers. It was founded in 2017 and is based in Xiamen, Fujian.
TheraPanacea is a medical technology company that focuses on the healthcare sector, specifically in the field of cancer care. The company offers AI-based software solutions for more efficient and precise cancer treatment planning and delivery, including adaptive radiotherapy and automatic delineation. TheraPanacea primarily serves the healthcare industry, with a particular emphasis on cancer centers and pharmaceutical companies. It was founded in 2017 and is based in Paris, France.
MIM Software is a company that focuses on providing practical imaging solutions in the healthcare sector, specifically in Radiation Oncology, Radiology, Nuclear Medicine, Urology, Neuroimaging, and Cardiac Imaging. The company's main offerings include computer workstation solutions, mobile and cloud-based platforms that streamline image reading and analysis for healthcare providers. MIM Software primarily sells to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies. It was founded in 2003 and is based in Cleveland, Ohio.
Limbus AI is a company that specializes in the healthcare technology sector, with a focus on radiation therapy. The company offers a product that uses artificial intelligence to automatically contour for radiation therapy, providing clinical grade contours backed by comprehensive research. This product is designed to be installed on existing computers, ensuring patient data remains local and secure. The company primarily serves the healthcare industry, particularly those involved in radiation therapy. It was founded in 2018 and is based in Regina, Saskatchewan.
MVision Private Equity Advisers is an independent international alternative assets advisory firm operating in the financial sector. The company primarily focuses on raising capital for Private Equity, Real Estate, Real Assets, Credit and Direct transactions. It primarily serves the financial industry, with a particular focus on private equity and real estate. It is based in London, England.